Home › Funds › Deer Management Co. LLC › TCRX
Deer Management Co. LLC position in TCRX
TScan Therapeutics Inc · Health Care
Deer Management Co. LLC reported holding 1,245,504 shares of TCRX (TScan Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$1.2M, representing 0.15% of its reported portfolio and ranking #9 among its reported holdings. Deer Management Co. LLC has disclosed TCRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deer Management Co. LLC's TCRX position evolved
Deer Management Co. LLC first disclosed a stake in TCRX in Q3 2023 at 1,245,505 shares (US$3.2M). The position peaked in Q1 2024 at 1,245,504 shares, worth US$9.9M. Across 12 filings, Deer Management Co. LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,245,504 shares valued at US$1.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.25M | $3.19M | New |
| Q4 2023 | 1.25M | $7.26M | Hold |
| Q1 2024 | 1.25M | $9.89M | Hold |
| Q2 2024 | 1.25M | $7.29M | Hold |
| Q3 2024 | 1.25M | $6.20M | Hold |
| Q4 2024 | 1.25M | $3.79M | Hold |
| Q1 2025 | 1.25M | $1.72M | Hold |
| Q2 2025 | 1.25M | $1.81M | Hold |
| Q3 2025 | 1.25M | $2.27M | Hold |
| Q4 2025 | 1.25M | $1.25M | Hold |
| Q1 2026 | 1.25M | $1.26M | Hold |
| Q2 2026 | 1.25M | $1.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TCRX and 13F data
TCRX (TScan Therapeutics Inc) is a Health Care company. 23 other funds we track also report a position in TCRX — the largest reported positions include DC Funds, LP (US$617.5M), Lynx1 Capital Management LP (US$7.9M), BVF INC/IL (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TCRX
- DC Funds, LP 630.00K sh · $617.46M · Q2 2026
- Lynx1 Capital Management LP 8.02M sh · $7.86M · Q2 2026
- BVF INC/IL 5.56M sh · $5.45M · Q2 2026
- Kalehua Capital Management LLC 454.88K sh · $445.82K · Q2 2026
More on Deer Management Co. LLC
FAQ
How long has Deer Management Co. LLC held TCRX?
Deer Management Co. LLC has disclosed TCRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Deer Management Co. LLC's current position in TCRX?
As of Q2 2026, Deer Management Co. LLC holds 1.25M shares of TCRX (TScan Therapeutics Inc), valued at $1.22M, representing 0.15% of its reported portfolio and ranking #9.
Has Deer Management Co. LLC been buying or selling TCRX?
In the latest 13F filing (Q2 2026), Deer Management Co. LLC held unchanged its position in TCRX. The position peaked in Q1 2024 at 1.25M shares.
Which other funds hold TCRX?
Other major institutional holders of TCRX include DC Funds, LP, Lynx1 Capital Management LP, BVF INC/IL, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.